Diana F. Nelson - Concepedia

Author

Diana F. Nelson

RTOG Foundation

Also Known As

D F Nelson, D. F. Nelson, D.F Nelson, D.F. Nelson, Diana F. Nelson, Diana Furst Nelson, Diana Nelson

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

RTOG Foundation University of Rochester University of Pennsylvania LDS Hospital Medical College of Wisconsin

About

Diana F. Nelson is an author at RTOG Foundation specializing in medicine, radiation oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	22	2.7K
2	Health Sciences	18	18	2.4K
3	Education	1	1	15
4	Engineering	1	1	30
5	Social Sciences	1	1	39

Diana F. Nelson

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials W.J. Curran, Charles Scott, John Horton, JNCI Journal of the National Cancer Institute	1993	1.3K
Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315 Diana F. Nelson, Karen Martz, Hugh Bonner, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyLymphoid NeoplasiaRtog 8315Radiation TherapyMedicine	1992	632
Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model Lauren E. Abrey, Leah Ben‐Porat, Katherine S. Panageas, Journal of Clinical Oncology	2006	607
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trials Joseph R. Simpson, John Horton, Charles Scott, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologySurgical OncologySurgical ResectionRadiation TherapyGlioblastoma Multiforme	1993	535
Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using rtog study 7916 Marie Diener‐West, Thomas W Dobbins, Theodore L. Phillips, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyPrognostic EvaluationMeta-analysisHealth SciencesMedicine	1989	205
A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: Final report of an RTOG study Diana F. Nelson, Marie Diener‐West, Alan S. Weinstein, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyRadiation MedicineSurgical OncologyRadiation TherapyGlioma	1986	172
Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma—Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the radiation therapy oncology group protocol 8302 Diana F. Nelson, Walter J. Curran, Charles Scott, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyMedicineRadionuclide TherapyCancer Treatment	1993	160
Disruption of the blood-brain barrier as the primary effect of CNS irradiation P. Rubin, Don M. Gash, John T. Hansen, Radiotherapy and Oncology Neuro-oncologyBlood–brain BarrierNeurophysiologyRadiation EffectRadiation Exposure	1994	157
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02 Maria Werner‐Wasik, Charles Scott, Diana F. Nelson, Cancer Adaptive RadiotherapyNeuro-oncologyLocal ControlGliomaRadiation Therapy	1996	153
White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (radiation therapy oncology group 83-02) Benjamin W. Corn, David M. Yousem, Charles Scott, Cancer	1994	137

Page 1